Prediction of Risk Factors for Progressive and Non-Progressive Stroke by Transcranial Doppler Ultrasound Information Technology

2020 ◽  
Vol 10 (9) ◽  
pp. 2136-2141
Author(s):  
Chunfeng Bai ◽  
Jing Lv ◽  
Sen Shao ◽  
Xiaofei Tang ◽  
Zhou Zhu
Keyword(s):  
Risk Factors ◽  
Information Technology ◽  
Doppler Ultrasound ◽  
Transcranial Doppler ◽  
Detection Rate ◽  
Transcranial Doppler Ultrasound ◽  
C Reactive Protein ◽  
Lipoprotein A ◽  
Reactive Protein ◽  
Progressive Group

Objective: To predict the risk factors of progressive and non-progressive stroke by the transcranial Doppler ultrasound information technology and the analysis of the comparative examination results. Methods: A total of 180 patients with ischemic stroke (IS) treated in the Neurology Department were included as the research objects. The Scandinavian Stroke Scale (SSS) was used to score the neurological functions of patients, and the patients were then divided into the progressive group (group P) and the non-progressive group (group NP). The carotid ultrasound examination was performed on the grouped patients, and the support vector machine (SVM) regression algorithm was used to classify the data obtained by the ultrasound examinations. The differences between the results of both groups were analyzed and discussed, as well as the carotid lesions and plaques. Results: The plaque detection rate was 96.7% in group P and 75.8% in group NP. In group P, the detection rate of the single plaque was 8.3%, and the detection rate of multiple plaques was 88.3%. In group NP, the detection rate of the single plaque was 19.2%, and the detection rate of multiple plaques was 56.7%. Besides, statistical differences existed between both groups (P < 0.01). Carotid plaques in both groups were mainly distributed in common carotid artery (CA), bifurcation, internal CA, and external CA. Of all the biochemical indexes and CPS, the fasting plasma glucose (FPS), low density lipoprotein-cholesterol, lipoprotein (a), homocysteine, C-reactive protein, and fibrinogen had positive correlations. The major risk factors for the formation of vulnerable carotid plaques were increased levels of lipoprotein (a), homocysteine, and C-reactive protein. Conclusion: The pathogenesis of progressive and non-progressive stroke was closely related to vulnerable plaque. The vulnerable plague was a factor indicating the risk of progressing to early stroke. Besides, the formation of vulnerable plaques was closely correlated to the increase of lipoprotein (a), homocysteine, and C-reactive protein levels.

Lipoprotein(a) and high-sensitive C-reactive protein as risk factors of coronary heart disease

2019 ◽  
Vol 10 (2) ◽  
pp. 189
Author(s):  
DebasisDebadatta Behera ◽  
Bratati Singh ◽  
SureshKumar Behera ◽  
Subhashree Ray ◽  
KamalLochan Das
Keyword(s):  
Risk Factors ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
C Reactive Protein ◽  
Lipoprotein A ◽  
Reactive Protein

Elevated Levels Of Lipoprotein(A) And C-Reactive Protein As Risk Factors Of Severe Atherosclerosis In Women

2019 ◽  
Vol 287 ◽  
pp. e229
Author(s):  
O. Afanasieva ◽  
E. Klesareva ◽  
E. Sherstyuk ◽  
M. Afanasieva ◽  
O. Razova ◽  
...  
Keyword(s):  
Risk Factors ◽  
C Reactive Protein ◽  
Lipoprotein A ◽  
Reactive Protein ◽  
Severe Atherosclerosis

scholarly journals Compare and correlate the levels of lipoprotein (a) and high-sensitive C-reactive protein in coronary heart disease with control

2019 ◽  
Vol 6 (3) ◽  
pp. 691
Author(s):  
Kamal Lochan Behera ◽  
Ashok Vankayala ◽  
Suresh Babu Sayana ◽  
D. S. S. K. Raju
Keyword(s):  
Risk Factors ◽  
Coronary Heart Disease ◽  
Heart Disease ◽  
Inflammatory Marker ◽  
Case Control ◽  
C Reactive Protein ◽  
Lipoprotein A ◽  
Reactive Protein ◽  
Patients With Diabetes ◽  
Hs Crp

Background: The incidence of ischemic heart disease/ myocardial infarction is rapidly increasing in India. However, the traditional risk factors alone could not explain this excess of Coronary Heart Disease (CHD). So, we are in need of a tool to assess the severity and prognosis of these acute coronary syndromes. Lipoprotein (a) [Lp(a)] and High Sensitive C-Reactive Protein (hs-CRP) have been recognised as independent risk factors for CHD in many retrospective case control studies. As the data shows inconsistency in the prediction of risk by Lp(a) and hs-CRP, the study is carried out to compare and correlate the levels of Lp(a) and hs-CRP in coronary heart disease patients with controls.Methods: An observational case control study was conducted at Maharaja’s Institute of Medical Sciences, Nellimarla, with 120 participants. 80 admitted with CHD were categorised as type 2 diabetic and non-diabetic. Remaining 40 participants were age matched controls, who have attended the OP for general health check-up. Samples collected from the participants were analysed for Lp(a), hs-CRP and HbA1c.Results: Lp(a) levels were significantly elevated in CHD patients with diabetes (69.2±27.5) and non-significant in CHD patients without diabetes (50.4±24.3) as compared to their controls (36.6±22.5). There was significant correlation and elevation of hs-CRP in CHD patients with diabetes (6.0±2.6) and without diabetes (3.7±2.0) as compared to their controls (0.7±0.4).Conclusions: The present study shows a lack of association of Lp(a) levels in CHD patients with and without diabetes. A strong correlation of the inflammatory marker, hs-CRP was observed between the CHD patients with and without diabetes and even as compared to their controls. It may be concluded that hs-CRP is a better and independent marker than Lp(a) in patients with CHD.

Complementary Effects of Multivitamin and Omega-3 Fatty Acid Supplementation on Indices of Cardiovascular Health in Individuals with Elevated Homocysteine

2012 ◽  
Vol 82 (1) ◽  
pp. 41-52 ◽  
Author(s):  
P. Earnest ◽  
S. Kupper ◽  
M. Thompson ◽  
Guo ◽  
S. Church
Keyword(s):  
Risk Factors ◽  
Cardiovascular Health ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
C Reactive Protein ◽  
Fatty Acid Supplementation ◽  
Omega 3 Fatty Acid ◽  
Reactive Protein ◽  
Daily Ingestion

Homocysteine (HCY), C-reactive protein (hsCRP), and triglycerides (TG) are risk factors for cardiovascular disease (CVD). While multivitamins (MVit) may reduce HCY and hsCRP, omega-3 fatty acids (N3) reduce TG; yet, they are seldom studied simultaneously. We randomly assigned 100 participants with baseline HCY (> 8.0 umol/L) to the daily ingestion of: (1) placebo, (2) MVit (VitC: 200 mg; VitE: 400 IU; VitB6: 25 mg; Folic Acid: 400 ug; VitB12: 400 ug) + placebo, (3) N3 (2 g N3, 760 mg EPA, 440 mg DHA)+placebo, or (4) MVit + N3 for 12 weeks. At follow-up, we observed significant reductions in HCY (umol/L) for the MVit (- 1.43, 95 %CI, - 2.39, - 0.47) and MVit + N3 groups (- 1.01, 95 %CI, - 1.98, - 0.04) groups, both being significant (p < 0.05) vs. placebo (- 0.57, 95 %CI, - 1.49, 0.35) and N3 (1.11, 95 % CI, 0.07, 2.17). hsCRP (nmol/L) was significantly reduced in the MVit (- 6.00, 95 %CI, - 1.04, - 0.15) and MVit + N3 (- 0.98, 95 %CI, - 1.51, - 0.46) groups, but not vs. placebo (- 0.15, 95 %CI, - 0.74, 0.43) or N3 (- 0.53, 95 %CI, - 1.18, 0.12). Lastly, we observed significant reductions in TG for the N3 (- 0.41, 95 %CI, - 0.69, - 0.13) and MVit + N3 (- 0.71, 95 %CI, - 0.93, - 0.46) groups, both significant vs. placebo (- 0.10, 95 %CI, - 0.36, 0.17) and MVit groups (0.15, 95 %CI, - 12, 0.42). The co-ingestion of MVit + N3 provides synergistic affects on HCY, hsCRP, and plasma TG.

scholarly journals FRI0420 ASSOCIATION BETWEEN RED BLOOD CELLS DISTRIBUTION WIDTH AND CARDIOVASCULAR RISK IN OSTEOARTHRITIS

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 808.2-808
Author(s):  
N. Hammam ◽  
G. Salem ◽  
D. Fouad ◽  
S. Rashad
Keyword(s):  
Risk Factors ◽  
Body Mass Index ◽  
Functional Limitations ◽  
Functional Limitation ◽  
C Reactive Protein ◽  
Cvd Risk Factors ◽  
Cvd Risk ◽  
Distribution Width ◽  
Reactive Protein ◽  
Lipid Panel

Background:Osteoarthritis (OA) is the most common joint disease that results in patient’s morbidity and disabilities. There is strong evidence that OA is a significant risk factor for cardiovascular disease (CVD). Red cell distribution width (RDW) blood test is a measure of the variation in red blood cell volume and size. Elevated RDW has recently been found to correlate with CVD risk in patients with and without heart disease and autoimmune diseases. RDW may be a marker for factors driving CVS risk.Objectives:: To investigate whether RDW can serve as a potential parameter for indicating cardiovascular risk in OA patients.Methods:A subsample of 819 OA patients was extracted from 2003-2006 National Health & Nutrition Examination Survey in a cross-sectional study. 63.7% of them were females. Their mean age was 66.4 ± 14.1 yrs. Demographic, medical data, inflammatory markers & lipid panel were obtained. Only patients with Haemoglobin>12 mg/dl were included. Functional limitations were assessed using a physical function questionnaire.Results:Elevated levels of RDW were associated with CVD risk factors in OA patients. 532 (65.8%) OA patients had functional limitations, while 78 (9.5%) and 63 (7.6%) known to have heart attacks or stroke ever. Mean RDW was 12.9±1.1fL. There was a positive significant correlation between RDW & CVD risk factors including body mass index (r=0.17, p<0.001), C-reactive protein (r=0.29, p<0.001), serum uric acid (r=0.12, p<0.001), and functional limitation (0.16, p<0.001). No significant association between RDW & lipid panel was found. In multiple regression analysis controlling for age, sex as covariates, body mass index (β =0.02, 95%CI: 0.01, 0.03, p=0.002), C-reactive protein (β =0.35, 95%CI: 0.26, 0.45, p<0.001), and functional limitation (β =0.18, 95%CI: 0.13, 0.35, p=0.03).Conclusion:In addition to known CVD risk in OA patients, elevated RDW levels should prompt physicians to aggressively screen and treat their patients for modifiable CVS risk factors, in addition to OA.Disclosure of Interests:None declared

Sign in / Sign up

Export Citation Format

Share Document